Cargando…
Lymphadenopathy and Splenomegaly
Lymphadenopathy and splenomegaly are benign and malignant processes that can produce common findings in children and it is important to distinguish between the two so that appropriate management can be undertaken. Lymphadenopathy might be caused by proliferation of cells intrinsic to the node, such...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149869/ http://dx.doi.org/10.1016/B978-0-12-375154-6.00015-X |
_version_ | 1783520901770248192 |
---|---|
author | Lanzkowsky, Philip |
author_facet | Lanzkowsky, Philip |
author_sort | Lanzkowsky, Philip |
collection | PubMed |
description | Lymphadenopathy and splenomegaly are benign and malignant processes that can produce common findings in children and it is important to distinguish between the two so that appropriate management can be undertaken. Lymphadenopathy might be caused by proliferation of cells intrinsic to the node, such as lymphocytes, plasma cells, monocytes or histiocytes or by infiltration of cells extrinsic to the node, such as neutrophils and malignant cells. Lymphadenopathy is also a presenting sign of malignancies such as leukemia, lymphoma, or neuroblastoma and it is important to be able to differentiate benign from malignant lymphadenopathy. Splenomegaly can be caused by diseases that result in hyperplasia of the lymphoid and reticuloendothelial systems, infiltrative disorders, hematologic disorders and conditions that cause distention of the sinusoids whenever there is increased pressure in the portal or splenic veins. The significance of splenomegaly depends on the underlying disease. In children, a palpable spleen may occasionally be due to visceroptosis rather than true splenomegaly. This distinction is important to make so that extensive investigations for the cause of splenomegaly are not undertaken unnecessarily. |
format | Online Article Text |
id | pubmed-7149869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71498692020-04-13 Lymphadenopathy and Splenomegaly Lanzkowsky, Philip Manual of Pediatric Hematology and Oncology Article Lymphadenopathy and splenomegaly are benign and malignant processes that can produce common findings in children and it is important to distinguish between the two so that appropriate management can be undertaken. Lymphadenopathy might be caused by proliferation of cells intrinsic to the node, such as lymphocytes, plasma cells, monocytes or histiocytes or by infiltration of cells extrinsic to the node, such as neutrophils and malignant cells. Lymphadenopathy is also a presenting sign of malignancies such as leukemia, lymphoma, or neuroblastoma and it is important to be able to differentiate benign from malignant lymphadenopathy. Splenomegaly can be caused by diseases that result in hyperplasia of the lymphoid and reticuloendothelial systems, infiltrative disorders, hematologic disorders and conditions that cause distention of the sinusoids whenever there is increased pressure in the portal or splenic veins. The significance of splenomegaly depends on the underlying disease. In children, a palpable spleen may occasionally be due to visceroptosis rather than true splenomegaly. This distinction is important to make so that extensive investigations for the cause of splenomegaly are not undertaken unnecessarily. 2011 2010-09-23 /pmc/articles/PMC7149869/ http://dx.doi.org/10.1016/B978-0-12-375154-6.00015-X Text en Copyright © 2011 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Lanzkowsky, Philip Lymphadenopathy and Splenomegaly |
title | Lymphadenopathy and Splenomegaly |
title_full | Lymphadenopathy and Splenomegaly |
title_fullStr | Lymphadenopathy and Splenomegaly |
title_full_unstemmed | Lymphadenopathy and Splenomegaly |
title_short | Lymphadenopathy and Splenomegaly |
title_sort | lymphadenopathy and splenomegaly |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149869/ http://dx.doi.org/10.1016/B978-0-12-375154-6.00015-X |
work_keys_str_mv | AT lanzkowskyphilip lymphadenopathyandsplenomegaly |